1. Home
  2. CHEK vs CTHR Comparison

CHEK vs CTHR Comparison

Compare CHEK & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • CTHR
  • Stock Information
  • Founded
  • CHEK 2004
  • CTHR 1995
  • Country
  • CHEK Israel
  • CTHR United States
  • Employees
  • CHEK N/A
  • CTHR N/A
  • Industry
  • CHEK Medical Electronics
  • CTHR Consumer Specialties
  • Sector
  • CHEK Health Care
  • CTHR Consumer Discretionary
  • Exchange
  • CHEK Nasdaq
  • CTHR Nasdaq
  • Market Cap
  • CHEK 4.5M
  • CTHR 4.1M
  • IPO Year
  • CHEK 2015
  • CTHR 1997
  • Fundamental
  • Price
  • CHEK $0.81
  • CTHR $0.98
  • Analyst Decision
  • CHEK
  • CTHR
  • Analyst Count
  • CHEK 0
  • CTHR 0
  • Target Price
  • CHEK N/A
  • CTHR N/A
  • AVG Volume (30 Days)
  • CHEK 52.9K
  • CTHR 11.8K
  • Earning Date
  • CHEK 05-14-2025
  • CTHR 05-01-2025
  • Dividend Yield
  • CHEK N/A
  • CTHR N/A
  • EPS Growth
  • CHEK N/A
  • CTHR N/A
  • EPS
  • CHEK N/A
  • CTHR N/A
  • Revenue
  • CHEK N/A
  • CTHR $23,684,860.00
  • Revenue This Year
  • CHEK N/A
  • CTHR $31.82
  • Revenue Next Year
  • CHEK N/A
  • CTHR N/A
  • P/E Ratio
  • CHEK N/A
  • CTHR N/A
  • Revenue Growth
  • CHEK N/A
  • CTHR N/A
  • 52 Week Low
  • CHEK $0.56
  • CTHR $0.93
  • 52 Week High
  • CHEK $3.04
  • CTHR $3.90
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 47.11
  • CTHR 36.50
  • Support Level
  • CHEK $0.77
  • CTHR $0.96
  • Resistance Level
  • CHEK $0.86
  • CTHR $1.03
  • Average True Range (ATR)
  • CHEK 0.08
  • CTHR 0.04
  • MACD
  • CHEK 0.00
  • CTHR 0.01
  • Stochastic Oscillator
  • CHEK 41.46
  • CTHR 37.50

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About CTHR Charles & Colvard Ltd

Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.

Share on Social Networks: